MedTrace Logo

Pharmacogenetics Study in Taiwan's Ethnic Groups

NCT00459251 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2007-04-11

No results posted yet for this study

Summary

This main purpose of this study is to understand the difference and distribution of drug-metabolizing enzyme genetic polymorphisms among Taiwan ethnicities. The subjects of study include Atayal, Pawlan, Yami, Tsou, Ami, Minnan and Hakka. We anticipate establishing a reference for the clinical medication in various ethnic groups according to the difference and distribution of the genetic polymorphisms.

Conditions

  • Healthy

Sponsors & Collaborators

  • Department of Health

    collaborator AMBIG

  • Mackay Memorial Hospital

    lead OTHER

Principal Investigators

  • Li-Jiuan Shen, Ph.D. · School of Pharmacy, National Taiwan University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Completion
2007-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00459251 on ClinicalTrials.gov